Products for Research Use Only
RegisterLogin

WYC-210

CAT: 0804-HY-136554-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-136554-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
WYC-210, a Tazarotene derivative, is a retinoid compound with lower anticancer activity[1]. WYC-210 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
CAS Number
2131803-93-3
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Drug Derivative
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/wyc-210.html
Purity
99.18
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(C1=CN=C(C#CC2=CC=C3C(C(C)(C)CCS3=O)=C2)N=C1)O
Molecular Formula
C18H16N2O3S
Molecular Weight
340.40
Precautions
H302, H315, H319, H335
References & Citations
[1]Cao, Xin, et al. Preparation of the retinoid compound and their application as anticancer agents. WO2017152725A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-124136-01WYC-209
HY-19350-01BML-210
HY-100003-01ML-210
HY-106915SG-210
HY-117614WF-210
HY-15861-01Targapremir-210
HY-161973Hydroxyl-ML-210
HY-162481Anticancer agent 210
HY-163508Antibacterial agent 210
HY-D1235Fluorescent brightener 210

Alternative Products

CatalogName
GTR19165624-01WYC-210
GKD80390-01WYC-209
A19001-50WYC-209 50mg
A19001-25WYC-209 25mg
A19001-5WYC-209 5mg
A19001-10WYC-209 10mg
A19001-1WYC-209 1mg
A19001-100WYC-209 100mg
MBS131442BML-210, (BML210; BML 210)
QY-E05678Human microRNA-210 (miR-210) ELISA

Popular Products